The appointment signals continued implementation of the July 2026 cooperation agreement with activist stockholders, but no new financial or operational catalysts are provided. Monitor for any future stockholder engagement outcomes or strategic shifts tied to the new committee.
Price Chart
Executive Summary
Vaxart appointed retired Vice Admiral Raquel C. Bono, M.D., to its Board of Directors effective October 16, 2026, pursuant to a cooperation agreement with a group of stockholders entered into in July 2026. Dr. Bono, a former Director of the Defense Health Agency and current Humana board member, will chair the new Stockholder Engagement Committee. This is a routine board appointment tied to a prior settlement with activist stockholders, carrying no immediate financial impact.
Key Facts
- Raquel C. Bono, M.D., appointed to Vaxart Board effective October 16, 2026
- Appointment made pursuant to a cooperation agreement with a group of stockholders entered into in July 2026
- Dr. Bono will serve as Chair of the Stockholder Engagement Committee and on the Nominating and Governance and Clinical and Regulatory Affairs Committees
- Dr. Bono is a retired U.S. Navy Vice Admiral and former Director of the Defense Health Agency
- She currently serves on the board of Humana Inc. (NYSE: HUM)
- No financial terms of the appointment or cooperation agreement disclosed
Financial Impact
No financial impact disclosed; standard non-employee director compensation applies
Risk Factors
- No financial or operational details disclosed — limited actionable information
- Cooperation agreement terms and stockholder group identity not disclosed in this filing
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-032932 |
| Exhibit: ex_1026920.htm | 0001437749-26-032932 |
| Document: 0001437749-26-032932-index-headers.html | 0001437749-26-032932 |
| Document: 0001437749-26-032932-index.html | 0001437749-26-032932 |
| Document: 0001437749-26-032932.txt | 0001437749-26-032932 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $0.4900 | awaiting T+60 | — | $0.4100 (−16.33%) |
Jul 28, 2026 13w ago | 8-K | $0.4800 $0.4900 | ▲ +2.08% | ▼ −2.53% | $0.4100 (−14.58%) |
Jul 7, 2026 16w ago | 8-K | $0.5500 $0.4500 | ▼ −18.18% | ▼ −21.27% | $0.4100 (−25.45%) |
Jul 6, 2026 16w ago | DEFA14A | $0.6200 $0.4540 | ▼ −26.77% | ▼ −28.93% | $0.4100 (−33.87%) |
Jul 2, 2026 16w ago | DEFA14A | $0.6400 $0.4500 | ▼ −29.69% | ▼ −33.51% | $0.4100 (−35.94%) |
Jul 2, 2026 16w ago | 8-K | $0.6400 $0.4520 | ▼ −29.38% | ▼ −32.80% | $0.4100 (−35.94%) |
Jun 26, 2026 17w ago | DEFA14A | $0.5700 $0.4900 | ▼ −14.04% | ▼ −17.08% | $0.4100 (−28.07%) |
Jun 26, 2026 17w ago | DEFA14A | $0.5700 $0.4900 | ▼ −14.04% | ▼ −17.08% | $0.4100 (−28.07%) |
Jun 26, 2026 17w ago | 8-K | $0.5700 $0.4900 | ▼ −14.04% | ▼ −17.08% | $0.4100 (−28.07%) |
Jun 16, 2026 19w ago | DEFA14A | $0.5600 $0.4987 | ▼ −10.95% | ▼ −12.21% | $0.4100 (−26.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers